1. Mankind Pharma
stock logo

50% Buy

Mankind Pharma Share Price

MANKIND

₹2,398.30+₹5.25 (0.22%) Past YearLast updated on 24 Apr, 2024 | 03:48 PM IST
₹2,375.00₹2,440.80
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

About

arrow

Market cap

Market Cap Switch₹95,863 Cr

Open

₹2,410.95

Close

₹2,393.05

Circuit range

₹2,632.35 - ₹2,153.75

Day range

₹2,375.00 - ₹2,440.80

Year range

₹1,242.00 - ₹2,490.00

Volume

5,69,613

Avg. traded

₹2,399.71

Revenue (12m)

₹9,946 Cr

Mankind PharmaMankind Pharma Limited is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It has a portfolio of formulations in several therapeutic areas, such as anti-infectives, cardiovascular, gastrointestinal, vitamins/minerals/nutrients, respiratory, anti-diabetic, dermatology, gynecology, and pain/analgesics, among others. Its other therapeutic areas include urology, ophthalmology, antiparasitic, stomatological, antineoplastic/immunomodulator, hepatoprotective, anti-malarial, blood-related, hormones, antiviral, sex stimulants/rejuvenators, anti-tuberculosis, parenteral and vaccines. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others.

Read more

Mankind Pharma Key indicators

arrow

52 week high

₹2,490.00

52 week low

₹1,242.00

P/E ratio

55.55

P/B ratio

10.79

ROE

17.43%

ROCE

21.2%

Dividend yield

--

Debt/Equity ratio

EPS

31.16

Learn more

Investment checklist: (2/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

50%

Hold

30%

Sell

20%

This analysis is based on the reviews of 10 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

21.96%

Net profit margin

14.73%

ROE

17.43%

ROA

13.63%

ROCE

21.2%

Learn more

Mankind Pharma Shareholder returns

arrow

1 day

+2.25%

1 week

+5.54%

1 month

+8.09%

3 months

+11.68%

1 year

+68.25%

3 years

+68.25%

5 years

+68.25%

Revenue statement

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Cash flow

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Balance sheet

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Mankind Pharma Share Price history

arrow
DayOpenCloseDay’s change
Tue, Apr 23 2024
₹2,369.90
₹2,393.05
+0.97%
Mon, Apr 22 2024
₹2,341.85
₹2,340.40
-0.06%
Fri, Apr 19 2024
₹2,350.05
₹2,337.45
-0.54%
Thu, Apr 18 2024
₹2,290.95
₹2,395.65
+4.37%
Tue, Apr 16 2024
₹2,247.35
₹2,281.05
+1.48%
Mon, Apr 15 2024
₹2,256.00
₹2,267.35
+0.50%
Fri, Apr 12 2024
₹2,348.25
₹2,320.35
-1.20%
Wed, Apr 10 2024
₹2,375.95
₹2,368.75
-0.30%

Shareholding info

arrow

Promoters (74.88%)

Mutual Funds (8.57%)

Retail and other (4.11%)

Foreign institutions-FII (9.87%)

Other domestic institutions (2.57%)

Promoters

Learn more

Events

Empty state

No data available at the moment

More

Similar stocks

arrow
Empty state

No data available at the moment

People also bought

arrow
Empty state

No data available at the moment

Frequently asked questions